209 related articles for article (PubMed ID: 31952070)
1. Downregulated AKT-mTOR signaling pathway proteins in dorsolateral prefrontal cortex in Schizophrenia.
Chadha R; Meador-Woodruff JH
Neuropsychopharmacology; 2020 May; 45(6):1059-1067. PubMed ID: 31952070
[TBL] [Abstract][Full Text] [Related]
2. mTOR kinase activity disrupts a phosphorylation signaling network in schizophrenia brain.
Chadha R; Alganem K; Mccullumsmith RE; Meador-Woodruff JH
Mol Psychiatry; 2021 Nov; 26(11):6868-6879. PubMed ID: 33990769
[TBL] [Abstract][Full Text] [Related]
3. PRR5, a novel component of mTOR complex 2, regulates platelet-derived growth factor receptor beta expression and signaling.
Woo SY; Kim DH; Jun CB; Kim YM; Haar EV; Lee SI; Hegg JW; Bandhakavi S; Griffin TJ; Kim DH
J Biol Chem; 2007 Aug; 282(35):25604-12. PubMed ID: 17599906
[TBL] [Abstract][Full Text] [Related]
4. Distinct signaling mechanisms of mTORC1 and mTORC2 in glioblastoma multiforme: a tale of two complexes.
Jhanwar-Uniyal M; Gillick JL; Neil J; Tobias M; Thwing ZE; Murali R
Adv Biol Regul; 2015 Jan; 57():64-74. PubMed ID: 25442674
[TBL] [Abstract][Full Text] [Related]
5. Diverse signaling mechanisms of mTOR complexes: mTORC1 and mTORC2 in forming a formidable relationship.
Jhanwar-Uniyal M; Wainwright JV; Mohan AL; Tobias ME; Murali R; Gandhi CD; Schmidt MH
Adv Biol Regul; 2019 May; 72():51-62. PubMed ID: 31010692
[TBL] [Abstract][Full Text] [Related]
6. mTORC1 and mTORC2 regulate insulin secretion through Akt in INS-1 cells.
Le Bacquer O; Queniat G; Gmyr V; Kerr-Conte J; Lefebvre B; Pattou F
J Endocrinol; 2013 Jan; 216(1):21-9. PubMed ID: 23092880
[TBL] [Abstract][Full Text] [Related]
7. Involvement of mTORC1 and mTORC2 in regulation of glioblastoma multiforme growth and motility.
Gulati N; Karsy M; Albert L; Murali R; Jhanwar-Uniyal M
Int J Oncol; 2009 Oct; 35(4):731-40. PubMed ID: 19724909
[TBL] [Abstract][Full Text] [Related]
8. mTOR Pathway in Papillary Thyroid Carcinoma: Different Contributions of mTORC1 and mTORC2 Complexes for Tumor Behavior and
Tavares C; Eloy C; Melo M; Gaspar da Rocha A; Pestana A; Batista R; Bueno Ferreira L; Rios E; Sobrinho Simões M; Soares P
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29757257
[TBL] [Abstract][Full Text] [Related]
9. Selective interference of mTORC1/RAPTOR protects against human disc cellular apoptosis, senescence, and extracellular matrix catabolism with Akt and autophagy induction.
Ito M; Yurube T; Kakutani K; Maeno K; Takada T; Terashima Y; Kakiuchi Y; Takeoka Y; Miyazaki S; Kuroda R; Nishida K
Osteoarthritis Cartilage; 2017 Dec; 25(12):2134-2146. PubMed ID: 28888905
[TBL] [Abstract][Full Text] [Related]
10. Dysregulation of the norepinephrine transporter sustains cortical hypodopaminergia and schizophrenia-like behaviors in neuronal rictor null mice.
Siuta MA; Robertson SD; Kocalis H; Saunders C; Gresch PJ; Khatri V; Shiota C; Kennedy JP; Lindsley CW; Daws LC; Polley DB; Veenstra-Vanderweele J; Stanwood GD; Magnuson MA; Niswender KD; Galli A
PLoS Biol; 2010 Jun; 8(6):e1000393. PubMed ID: 20543991
[TBL] [Abstract][Full Text] [Related]
11. High prevalence of mTOR complex activity can be targeted using Torin2 in papillary thyroid carcinoma.
Ahmed M; Hussain AR; Bavi P; Ahmed SO; Al Sobhi SS; Al-Dayel F; Uddin S; Al-Kuraya KS
Carcinogenesis; 2014 Jul; 35(7):1564-72. PubMed ID: 24583924
[TBL] [Abstract][Full Text] [Related]
12. RES-529: a PI3K/AKT/mTOR pathway inhibitor that dissociates the mTORC1 and mTORC2 complexes.
Weinberg MA
Anticancer Drugs; 2016 Jul; 27(6):475-87. PubMed ID: 26918392
[TBL] [Abstract][Full Text] [Related]
13. Discrete signaling mechanisms of mTORC1 and mTORC2: Connected yet apart in cellular and molecular aspects.
Jhanwar-Uniyal M; Amin AG; Cooper JB; Das K; Schmidt MH; Murali R
Adv Biol Regul; 2017 May; 64():39-48. PubMed ID: 28189457
[TBL] [Abstract][Full Text] [Related]
14. Activation of Mechanistic Target of Rapamycin (mTOR) in Human Endothelial Cells Infected with Pathogenic Spotted Fever Group Rickettsiae.
Sahni A; Narra HP; Sahni SK
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003310
[TBL] [Abstract][Full Text] [Related]
15. mTORC2 Balances AKT Activation and eIF2α Serine 51 Phosphorylation to Promote Survival under Stress.
Tenkerian C; Krishnamoorthy J; Mounir Z; Kazimierczak U; Khoutorsky A; Staschke KA; Kristof AS; Wang S; Hatzoglou M; Koromilas AE
Mol Cancer Res; 2015 Oct; 13(10):1377-88. PubMed ID: 26130148
[TBL] [Abstract][Full Text] [Related]
16. The functions of mTOR in ischemic diseases.
Hwang SK; Kim HH
BMB Rep; 2011 Aug; 44(8):506-11. PubMed ID: 21871173
[TBL] [Abstract][Full Text] [Related]
17. Reduced menin expression impairs rapamycin effects as evidenced by an increase in mTORC2 signaling and cell migration.
Razmara M; Monazzam A; Skogseid B
Cell Commun Signal; 2018 Oct; 16(1):64. PubMed ID: 30285764
[TBL] [Abstract][Full Text] [Related]
18. Role of the phosphoinositide 3-kinase-Akt-mammalian target of the rapamycin signaling pathway in long-term potentiation and trace fear conditioning memory in rat medial prefrontal cortex.
Sui L; Wang J; Li BM
Learn Mem; 2008 Oct; 15(10):762-76. PubMed ID: 18832563
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia-induced endothelial proliferation requires both mTORC1 and mTORC2.
Li W; Petrimpol M; Molle KD; Hall MN; Battegay EJ; Humar R
Circ Res; 2007 Jan; 100(1):79-87. PubMed ID: 17110594
[TBL] [Abstract][Full Text] [Related]
20. Prevention of Akt phosphorylation is a key to targeting cancer stem-like cells by mTOR inhibition.
Matsubara S; Tsukasa K; Kuwahata T; Takao S
Hum Cell; 2020 Oct; 33(4):1197-1203. PubMed ID: 32851605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]